P300/CBP-associated factor (PCAF)-mediated acetylation of LDHB reduces LDHB activity and inhibits lactate clearance, leading to lactate accumulation, which exacerbates lipid deposition and inflammatory responses in NAFLD and NAFLD progression (90). This evidence concerns the gene LDHB and metabolic dysfunction-associated steatotic liver disease.